A Single Nucleotide Polymorphism in Tyk2 Controls Susceptibility to Experimental Allergic Encephalomyelitis1
暂无分享,去创建一个
W. Hickey | C. Teuscher | E. Blankenhorn | K. Spach | R. Noubade | Benjamin D McElvany | Cory Teuscher
[1] James Wason,et al. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor , 2009, European Journal of Human Genetics.
[2] Jan Hillert,et al. Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions , 2009, neurogenetics.
[3] B. Engelhardt,et al. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier , 2008, Journal of Neuroimmunology.
[4] J. Rioux,et al. Autoimmune diseases: insights from genome-wide association studies. , 2008, Human molecular genetics.
[5] P. Sørensen,et al. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis. , 2008, Clinical immunology.
[6] B. Hemmer,et al. Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis. , 2008, Clinical immunology.
[7] S. Neuhausen,et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. , 2008, Journal of autoimmunity.
[8] A. Proudfoot,et al. The use of chemokine antagonists in EAE models , 2008, Journal of Neuroimmunology.
[9] N. Simister,et al. Activation of the JAK/STAT-1 Signaling Pathway by IFN-γ Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG1 , 2008, The Journal of Immunology.
[10] C. Teuscher,et al. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3 , 2008, Genes and Immunity.
[11] E. Jacobson,et al. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. , 2008, Endocrine reviews.
[12] W. Bremner,et al. Advances in male contraception. , 2008, Endocrine reviews.
[13] J. Zachary,et al. Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. , 2007, The Journal of clinical investigation.
[14] N. Watanabe,et al. Expression of Tyk2 in dendritic cells is required for IL-12, IL-23, and IFN-gamma production and the induction of Th1 cell differentiation. , 2007, Blood.
[15] J. Erälinna,et al. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[16] J. Gauldie,et al. IFN-γ-Induced Chemokines Synergize with Pertussis Toxin to Promote T Cell Entry to the Central Nervous System1 , 2007, The Journal of Immunology.
[17] D. C. Graham,et al. Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families. , 2007, Rheumatology.
[18] Xin Chen,et al. Pertussis Toxin by Inducing IL-6 Promotes the Generation of IL-17-Producing CD4 Cells1 , 2007, The Journal of Immunology.
[19] A. Ascherio,et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.
[20] J. Haines,et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study , 2006, The Lancet Neurology.
[21] W. Valdar,et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.
[22] T. Morio,et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. , 2006, Immunity.
[23] J. Zachary,et al. Evidence that the Y chromosome influences autoimmune disease in male and female mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Rajasingh,et al. 1,25 dihydroxyvitamin‐D3 modulates JAK–STAT pathway in IL‐12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis , 2006 .
[25] G. Rosati,et al. Glatiramer acetate reduces lymphocyte proliferation and enhances IL‐5 and IL‐13 production through modulation of monocyte‐derived dendritic cells in multiple sclerosis , 2006, Clinical and experimental immunology.
[26] J. Kere,et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. , 2005, American journal of human genetics.
[27] Kutty Selva Nandakumar,et al. Identification of epistasis through a partial advanced intercross reveals three arthritis loci within the Cia5 QTL in mice , 2005, Genes and Immunity.
[28] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[29] Yuka Kanno,et al. Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4 , 2004, Immunological reviews.
[30] J. Bright,et al. Quercetin, a Flavonoid Phytoestrogen, Ameliorates Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through JAK-STAT Pathway in T Lymphocyte , 2004, Journal of Clinical Immunology.
[31] C. Polman,et al. Multiple sclerosis and vitamin D: an update , 2004, European Journal of Clinical Nutrition.
[32] M. Goldacre,et al. Skin cancer in people with multiple sclerosis: a record linkage study , 2004, Journal of epidemiology and community health.
[33] L. Birnbaumer,et al. TCR‐mediated hyper‐responsiveness of autoimmune Gαi2‐/‐ mice is an intrinsic naïve CD4+ T cell disorder selective for the Gαi2 subunit , 2003 .
[34] W. Dietrich,et al. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Dwyer,et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.
[36] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[37] K. Nakayama,et al. Enhanced Th2 Cell-Mediated Allergic Inflammation in Tyk2-Deficient Mice1 , 2003, The Journal of Immunology.
[38] M. Goldman,et al. Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns , 2002, European journal of immunology.
[39] J. Zachary,et al. Identification of Bphs, an Autoimmune Disease Locus, as Histamine Receptor H1 , 2002, Science.
[40] T. Forsthuber,et al. Pertussis Toxin Modulates the Immune Response to Neuroantigens Injected in Incomplete Freund’s Adjuvant: Induction of Th1 Cells and Experimental Autoimmune Encephalomyelitis in the Presence of High Frequencies of Th2 Cells1 , 2002, The Journal of Immunology.
[41] T. Mcclanahan,et al. A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.
[42] S. Bhattacharya,et al. Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.
[43] J. McQualter,et al. Granulocyte Macrophage Colony-Stimulating Factor A New Putative Therapeutic Target in Multiple Sclerosis , 2001 .
[44] Terence Dwyer,et al. Regional Variation in Multiple Sclerosis Prevalence in Australia and Its Association with Ambient Ultraviolet Radiation , 2001, Neuroepidemiology.
[45] A. Sher,et al. A Heritable Defect in IL-12 Signaling in B10.Q/J Mice. I. In Vitro Analysis , 2001, The Journal of Immunology.
[46] A. Sher,et al. A Heritable Defect in IL-12 Signaling in B10.Q/J Mice. II. Effect on Acute Resistance to Toxoplasma gondii and Rescue by IL-18 Treatment , 2001, The Journal of Immunology.
[47] H. Lassmann,et al. Screening of several H-2 congenic mouse strains identified H-2q mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement , 2000, Journal of Neuroimmunology.
[48] M. Shibamori,et al. Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. , 2000, Immunity.
[49] H. Pircher,et al. Partial impairment of cytokine responses in Tyk2-deficient mice. , 2000, Immunity.
[50] R. Vieth,et al. Vitamin D and seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis , 2000, Annals of neurology.
[51] R. Doerge,et al. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. , 2000, The American journal of pathology.
[52] Mustafa Dosemeci,et al. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates , 2000, Occupational and environmental medicine.
[53] A. Iwasaki,et al. Primary Role for GI Protein Signaling in the Regulation of Interleukin 12 Production and the Induction of T Helper Cell Type 1 Responses , 2000, The Journal of experimental medicine.
[54] R. Doerge,et al. Genetic Analysis of the Influence of Pertussis Toxin on Experimental Allergic Encephalomyelitis Susceptibility: An Environmental Agent Can Override Genetic Checkpoints1 , 2000, The Journal of Immunology.
[55] R. Doerge,et al. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. , 1999, Journal of immunology.
[56] J. Trent,et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Todd,et al. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. , 1998, Journal of immunology.
[58] V. Provitera,et al. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. , 1998, Immunopharmacology and immunotoxicology.
[59] R. Rappuoli,et al. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. , 1998, International immunology.
[60] R. Doerge,et al. Evidence that Tmevd2 and eae3 may represent either a common locus or members of a gene complex controlling susceptibility to immunologically mediated demyelination in mice. , 1997, Journal of immunology.
[61] W. Cowden,et al. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. , 1996, Journal of immunology.
[62] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[63] A. Sher,et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.
[64] J. Lunceford,et al. Aod2, the locus controlling development of atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis, co-localizes with Il2, Fgfb, and Idd3 , 1996, The Journal of experimental medicine.
[65] L. Steinman,et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). , 1996, Journal of immunology.
[66] K. Winestock,et al. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. , 1995, Journal of immunology.
[67] M. Welham,et al. Interleukin-13 Signal Transduction in Lymphohemopoietic Cells , 1995, The Journal of Biological Chemistry.
[68] L. Velazquez,et al. Distinct Domains of the Protein Tyrosine Kinase tyk2 Required for Binding of Interferon-/ and for Signal Transduction * , 1995, The Journal of Biological Chemistry.
[69] R. Rees,et al. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL- 12 , 1995, The Journal of experimental medicine.
[70] G. Yancopoulos,et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.
[71] H. Kaslow,et al. Pertussis toxin and target eukaryotic cells: binding, entry, and activation , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[72] D. Paty,et al. A population-based study of multiple sclerosis in twins. , 1986, The New England journal of medicine.
[73] M. Vadas,et al. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice , 1983, The Journal of experimental medicine.
[74] J. Frelinger,et al. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes , 1982, The Journal of experimental medicine.
[75] K. Hirokawa,et al. Experimental allergic orchitis in mice , 1981, Virchows Archiv A.
[76] 徳政 直起. Expression of Tyk2 in dendritic cells is required for IL-12, IL-23, and IFN-γ production and the induction of Th1 cell differentiation , 2007 .
[77] W. Leonard,et al. Jaks and STATs: biological implications. , 1998, Annual review of immunology.